You are here

  • Home
  • Archive
  • Volume 8, Issue 5
  • Psychotherapy or paroxetine did not reduce abdominal pain, but may improve quality of life in irritable bowel syndrome

Article Text

Article menu
Download PDFPDF
Economics
Psychotherapy or paroxetine did not reduce abdominal pain, but may improve quality of life in irritable bowel syndrome

https://doi.org/10.1136/ebm.8.5.160

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2003) Gastroenterology 124, 303. Creed F, Fernandes L, Guthrie E, et al.. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome.. ;. :. –17.
    OpenUrlCrossRefPubMedWeb of Science

    
 
 QUESTION: In patients with severe irritable bowel syndrome (IBS), is psychotherapy or paroxetine more effective than usual care for reducing abdominal pain, and improving health related quality of life (HRQL), without incurring additional costs?

    Design

    Cost effectiveness analysis of a randomised (allocation concealed*), blinded (clinicians, {data collectors, data analysts, and data safety and monitoring committee}†),* controlled trial with follow up at 3 and 15 months.

    Setting

    7 gastroenterology clinics in the UK.

    Patients

    257 patients 18–65 years of age (mean age 40 y, 80% women) who met Rome I criteria for IBS, had symptoms for >6 months, failed to respond to “usual” medical treatment (antispasmodics and laxatives or antidiarrhoeal medication given for ≥3 mo), had severe abdominal pain (visual analogue scale >59), had no contraindication to psychotherapy or paroxetine, and were able to complete the study questionnaires. …

    View Full Text